Patients and families allege that GLP‑1 medicines such as Ozempic can cause optic neuropathy, but research has not established how often the condition occurs.
Posts tagged as “Ozempic”
Researchers in Louisiana are investigating the impact of weight loss drugs like Ozempic on muscle mass and metabolism, aiming to address potential drawbacks of the popular medications.
New research indicates that individuals taking GLP-1 medications for weight loss may decrease their physical activity levels, prompting calls for integrated exercise recommendations.
Emerging research suggests that GLP-1 receptor agonists, commonly used for diabetes and weight loss, may also offer a protective effect against certain cancers. Scientists are actively investigating the underlying mechanisms.